What is IQVIA's stock-based comp?

IQVIA (IQV) reported stock-based comp of $95M in Q2 2026.

How has IQVIA's stock-based comp changed year-over-year?

IQVIA's stock-based comp increased by 58.3% year-over-year, from $60M to $95M.

What is the long-term trend for IQVIA's stock-based comp?

Over 4 years (2021 to 2025), IQVIA's stock-based comp has grown at a 9.8% compound annual growth rate (CAGR), from $170M to $247M.

IQVIA IQV Stock-Based Comp

Stock-Based Comp at other companies

Thermo Fisher ScientificTMO

——

Veeva SystemsVEEV

——

AccentureACN

——

ClarivateCLVT

——

Other financials

Income statement

See full

Revenue$4.4B+8.7%

Gross profit$1.4B+8.5%

Operating income$506.0M0.0%

Net income$256.0M-3.8%

EPS (diluted)$1.53-0.6%

Balance sheet

See full

Cash & equivalents$1.9B-6.4%

Total debt$16.2B+3.4%

Total equity$6.2B+6.8%

Total assets$29.9B+4.4%

Cash flow

See full

Operating cash flow$558.0M+26.0%

CapEx$198.0M+31.1%

Free cash flow$360.0M+23.3%

Valuation

See full

Market cap$39.99B+20.9%

Enterprise value$54.32B+16.2%

P/E29.1×+2.3×

P/S2.4×+0.2×

Profitability

See full

Gross margin33%-1.3pp

Operating margin13%-0.9pp

Net margin8.1%+0.2pp

FCF margin12.9%+0.1pp

Returns & leverage

See full

Return on equity23%+3.2pp

Debt / equity2.6×-0.1×

Current ratio0.7×-0.1×

Where this comes from

Reported directly by IQVIA in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: IQVIA’s 10-Q, filed July 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about IQVIA's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is IQVIA's stock-based comp?: IQVIA (IQV) reported stock-based comp of $95M in Q2 2026.
How has IQVIA's stock-based comp changed year-over-year?: IQVIA's stock-based comp increased by 58.3% year-over-year, from $60M to $95M.
What is the long-term trend for IQVIA's stock-based comp?: Over 4 years (2021 to 2025), IQVIA's stock-based comp has grown at a 9.8% compound annual growth rate (CAGR), from $170M to $247M.